| Net income (loss) | -13.76M |
| Depreciation and amortization | |
| Impairment charge (Notes A and I) | |
| Stock-based compensation | 639K |
| Deferred income taxes | |
| Gain on disposition of assets | |
| Accounts receivable | 13.23M |
| Inventory | -7.78M |
| Accounts payable | -3.4M |
| Accrued and recoverable taxes | 1.16M |
| Other elements of working capital | -2.39M |
| Other long-term, net | -533K |
| Cash provided from operating activities | 9.51M |
| Capital expenditures | -3.2M |
| Acquisition (Note G) | -482K |
| Prepublication costs | -1.26M |
| Proceeds on disposition of assets | |
| Short-term investments | |
| Cash used for investment activities | -5.27M |
| Long-term debt borrowings, net | |
| Cash dividends | -4.83M |
| Proceeds from stock plans | 943K |
| Cash provided from (used for) financing activities | -6.63M |
| Decrease in cash and cash equivalents | -2.5M |
| Cash and cash equivalents at the beginning of the period | 4.14M |
| Cash and cash equivalents at the end of the period | 1.65M |
| Contingent consideration (Note G) | |